Platinum
CAS 7440-06-4
Platinum (CAS 7440-06-4) is a pharmaceutical compound with 0 bioactivity targets and 33 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Platinum is linked through DSSTox identifiers.
View industrial chemical data →Pharmacogenomics
Drug-gene phenotype annotations and evidence levels from PharmGKB-mapped rows.
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Platinum used for in pharmaceutical contexts?
Platinum (CAS 7440-06-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Platinum?
Platinum has 33 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Adrenal insufficiency, Adverse event, Alanine aminotransferase increased, Anaemia, Aspartate aminotransferase increased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Platinum also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Platinum with EU status "restricted".
What clinical phase is Platinum in?
No phase 1-4 clinical development badge is rendered for Platinum because the matched compound identifier rows do not contain a max-phase value.